Menu
Search
|

Menu

Close
X

Sanofi SA SASY.PA (Paris Stock Exchange)

79.23 EUR
-- (--)
As of Nov 16
chart
Previous Close 79.23
Open --
Volume --
3m Avg Volume 2,468,222
Today’s High --
Today’s Low --
52 Week High 80.44
52 Week Low 62.88
Shares Outstanding (mil) 1,251.76
Market Capitalization (mil) 100,403.50
Forward P/E 25.03
Dividend (Yield %) 3.03 ( 3.78 )

LATEST NEWS

ADVERTISEMENT

RECOMMENDATION

Sell Hold Buy
2.12 Mean rating from 24 analysts

KEY STATS

Revenue (mm, EUR)
FY18
26,351
FY17
45,617
FY16
44,003
FY15
43,922
EPS (EUR)
FY18
3.247
FY17
4.167
FY16
4.679
FY15
4.587
*Note: Units in Millions of Euro
**Note: Units in Euro

KEY RATIOS

Price to Earnings (TTM)
vs sector
25.03
29.34
Price to Sales (TTM)
vs sector
2.84
20.58
Price to Book (MRQ)
vs sector
--
4.23
Price to Cash Flow (TTM)
vs sector
17.03
21.19
Total Debt to Equity (MRQ)
vs sector
--
13.84
LT Debt to Equity (MRQ)
vs sector
--
9.93
Return on Investment (TTM)
vs sector
--
13.58
Return on Equity (TTM)
vs sector
--
15.11

EXECUTIVE LEADERSHIP

Serge Weinberg
Independent Chairman of the Board, Since 2015
Salary: €700,000.00
Bonus: --
Olivier Brandicourt
Chairman of the Executive Committee, Chief Executive Officer, Director, Since 2015
Salary: €895,455.00
Bonus: --
Jean-Baptiste Chasseloup de Chatillon
Chief Financial Officer, Executive Vice President, Member of the Executive Committee, Since 2018
Salary: --
Bonus: --
Karen Linehan
Executive Vice President - Legal Affairs and General Counsel, Member of the Executive Committee, Since 2014
Salary: --
Bonus: --
Roberto Pucci
Executive Vice President - Human Resources, Member of the Executive Committee, Since 2009
Salary: --
Bonus: --

COMPANY PROFILE

Sector: Healthcare
Industry: Pharmaceuticals
Address:

54 rue la Boetie
PARIS     75008

Phone: +331.53774000

Sanofi is a healthcare company, focused on patient needs and engaged in the research, development, manufacture and marketing of therapeutic solutions. Its segments are Pharmaceuticals, Human Vaccines (Vaccines), and Other. The Pharmaceuticals segment comprises the commercial operations of various franchises, including Speciality Care (Rare Diseases, Multiple Sclerosis, and Oncology), Diabetes and Cardiovascular, Established Prescription Products, Consumer Healthcare and Generics, and research and development, production and marketing activities for all of the Company's pharmaceuticals operations. The Vaccines segment is dedicated to vaccines and includes the commercial operations of the Company's vaccines division Sanofi Pasteur and dedicated research and development, production and marketing activities for the Company's vaccines operations. Its Rare Diseases products include Cerezyme, Cerdelga, Myozyme and Lumizyme, Fabrazyme, and Aldurazyme. It partners with Alnylam Pharmaceuticals.

SPONSORED STORIES